Treatment response assessment of glioma tumors using deep learning based on magnetic resonance imaging
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: U-Net segmentation and transfer-learned classification are applied to MRI before and after glioma radiotherapy, with the segmented volumes used to assess treatment response in 49 patients; this is a specific clinical imaging result.
Technology: U-Net segmentation and transfer-learned MRI classifier
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Segments glioma volumes on pre- and post-radiotherapy MRI and classifies treatment response in the reported 49-patient cohort.
- Limitation / still unknown
- The reported evaluation does not establish prospective benefit or performance beyond the studied setting.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.researchsquare.com/article/rs-2733829/v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.